TEAD4 and neoplasm: In vivo, silencing of TEAD4 by shRNA (Fig. 7h, i and Supplementary Fig. 4c) or CRISPR-Cas9 KO of both TEAD4 alleles (Fig. 7j, k and Supplementary Fig. 4d) significantly suppressed the tumor growth.